Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells

INTRODUCTION: Pancreatic cancer (PC) is one of the leading causes of cancer, with the lowest 5-year survival rate of all cancer types. Given the fast metastasis of PC and its resistance to surgery, radiotherapy, chemotherapy, and combinations thereof, it is imperative to develop more effective anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongchun, Chen, Miao, Yang, Zhuying, Wang, Qinxian, Wang, Jiesheng, Jin, Dong, Yang, Xiuyun, Chen, Fuxing, Zhou, Xiumin, Luo, Kexue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138621/
https://www.ncbi.nlm.nih.gov/pubmed/32308417
http://dx.doi.org/10.2147/OTT.S238958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138621/
https://www.ncbi.nlm.nih.gov/pubmed/32308417
http://dx.doi.org/10.2147/OTT.S238958

Ejemplares similares